Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLNC Cigarettes for Smoking Cessation
NCT02796391Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Sep 2017
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
A Phase 2 trial of cigarette reduced nicotine in nicotine dependence, sponsored by Moffitt Cancer Center. Started Sep 2017; status: completed.
02
Drugs
cigarette reduced nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02796391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796391.